Thermo Fisher plans to sell parts of diagnostics unit for $4 billion, FT reports
How did your country report this? Share your view in the comments.
Diverging Reports Breakdown
Thermo Fisher plans to sell parts of diagnostics unit for $4 billion, FT reports
The contract drug manufacturer recently enlisted advisers to explore private equity interest in part of its diagnostics business. The auction process does not guarantee a sale, the report said, adding that Thermo Fisher may decide to retain the asset. The company acquired Solventum’s purification and filtration business for about $4.1 billion in cash in February.
Companies Thermo Fisher Scientific Inc Follow
June 12 (Reuters) – Thermo Fisher Scientific (TMO.N) , opens new tab plans to sell its diagnostics unit for about $4 billion in an attempt to offload some of its low-growth assets, the Financial Times reported on Thursday, citing people familiar with the matter.
The contract drug manufacturer recently enlisted advisers to explore private equity interest in part of its diagnostics business, including its microbiology unit, which produces infectious disease testing equipment, according to the Financial Times.
Sign up here.
The auction process does not guarantee a sale, the report said, adding that Thermo Fisher may decide to retain the asset.
Thermo Fisher did not immediately respond to a Reuters’ request for comment.
In February, the company acquired Solventum’s purification and filtration business for about $4.1 billion in cash.
Reporting by Dheeraj Kumar in Bengaluru; Editing by Alan Barona and Sherry Jacob-Phillips
Our Standards: The Thomson Reuters Trust Principles. , opens new tab